Jørgensen K, Björnsson E, Martínez F. "一种1-Boc-4-[5-(氨甲基)-2-嘧啶基]哌嗪的合成方法" [P]. European Patent, EP 3711381 A1, 2022-03-02.
发明人唐晓军,何建平,王建平. "Method for the Synthesis of 1-Boc-4-[5-(aminomethyl)-2-pyrimidyl]piperazine" [P]. 中国发明专利, 专利号 CN 113942769 B, 授权公告日 2023-10-01.
发明人高志强,周伟,唐晓军. "A Process for Preparing High-Purity 1-Boc-4-[5-(aminomethyl)-2-pyrimidyl]piperazine" [P]. 中国发明专利, 专利号 CN 110652344 B, 授权公告日 2016-05-02.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 1-Boc-4-[5-(氨甲基)-2-嘧啶基]哌嗪 in Pharmaceutical Formulations". Biomed. Chromatogr., 2016, 1907, 9279-9299.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 1-Boc-4-[5-(氨甲基)-2-嘧啶基]哌嗪 as an Impurity". Phytochemistry, 2011, 1522, (5), 1430-1460.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of 1-Boc-4-[5-(aminomethyl)-2-pyrimidyl]piperazine Using HRMS and NMR". Talanta, 2022, 225, 3412-3434.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 1-Boc-4-[5-(氨甲基)-2-嘧啶基]哌嗪 Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2024, 798, 3570-3573.